| 1-(4-METHOXYPHENYL)-1-CYCLOPROPANECARBOXYLIC ACID |
1-(4-甲氧基）-1-环丙烷羧酸 |
16728-01-1 |
| N,N'-Bis(dimethylaminomethylene)hydrazine |
N,N'-双(二甲基氨基亚甲基)肼 |
16114-05-9 |
| TETRAMETHYL METHYLENEDIPHOSPHONATE |
四甲基亚甲基二磷酸酯 |
16001-93-7 |
| 3-Hydroxy-cyclobutanon |
3-羟基环丁酮 |
15932-93-1 |
| 5-(METHOXYMETHYLENE)-2,2-DIMETHYL-1,3-DIOXANE-4,6-DIONE |
5-(甲氧亚甲基)-2,2-二甲基-1,3-二氧杂环已烷-4,6-二酮 |
15568-85-1 |
| 2-BROMO-1-[3,5-DI(TERT-BUTYL)-4-HYDROXYPHENYL]ETHAN-1-ONE |
2-溴-1-[3,5-二(叔丁基)-4-羟基苯基]乙酮 |
14386-64-2 |
| 2,4,6-TRIMETHOXYANILINE |
2,4,6-三甲氧基苯胺 |
14227-17-9 |
| 2-BROMO-1-NAPHTHALEN-1-YL-ETHANONE |
2-溴-1-萘-1-乙酮 |
13686-51-6 |
| 3-OXO-3-THIOPHEN-2-YL-PROPIONIC ACID ETHYL ESTER |
2-噻吩甲酰乙酸乙酯 |
13669-10-8 |
| 5-bromo-3-fluoro-2-nitropyridine |
5-溴-3-氟-2-硝基吡啶 |
1532517-95-5 |
| GNE-9605 |
GNE-9605 |
1536200-31-3 |
| GNE-3511 |
化合物GNE-3511 |
1496581-76-0 |
| M-5717 |
1469439-69-7 |
1469439-69-7 |
| N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide |
GSK2981278 |
1474110-21-8 |
| Nrf1-activator-1 |
NRF1-ACTIVATOR-1 |
1474034-05-3 |
| ASP5878 |
ASP-5878 |
1453208-66-6 |
| PU-WS13 |
6-氨基-8-[(3,5-二氯苯基)硫基]-N-异丙基-9H-嘌呤-9-丙胺 |
1454619-14-7 |
| Lorlatinib (PF-06463922) |
劳拉替尼 |
1454846-35-5 |
| 4-(4-(5,5-diMethyl-4,5-dihydrothiazol-2-yl)piperazin-1-yl)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyriMidine |
4-(4-(5,5-diMethyl-4,5-dihydrothiazol-2-yl)piperazin-1-yl)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyriMidine |
1454920-20-7 |
| SH5-07 |
1456632-41-9 |
1456632-41-9 |
QQ
